{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,14]],"date-time":"2026-05-14T01:09:20Z","timestamp":1778720960092,"version":"3.51.4"},"reference-count":53,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2020,6,1]],"date-time":"2020-06-01T00:00:00Z","timestamp":1590969600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,6,1]],"date-time":"2020-06-01T00:00:00Z","timestamp":1590969600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100003968","name":"Iran National Science Foundation","doi-asserted-by":"publisher","award":["94010235"],"award-info":[{"award-number":["94010235"]}],"id":[{"id":"10.13039\/501100003968","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004320","name":"Shiraz University of Medical Sciences","doi-asserted-by":"publisher","award":["18240"],"award-info":[{"award-number":["18240"]}],"id":[{"id":"10.13039\/501100004320","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004320","name":"Shiraz University of Medical Sciences","doi-asserted-by":"publisher","award":["S593"],"award-info":[{"award-number":["S593"]}],"id":[{"id":"10.13039\/501100004320","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Human Immunology"],"published-print":{"date-parts":[[2020,6]]},"DOI":"10.1016\/j.humimm.2020.03.004","type":"journal-article","created":{"date-parts":[[2020,3,18]],"date-time":"2020-03-18T11:40:10Z","timestamp":1584531610000},"page":"285-292","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"title":["Impact of donor KIRs and recipient KIR\/HLA class I combinations on GVHD in patients with acute leukemia after HLA-matched sibling HSCT"],"prefix":"10.1016","volume":"81","author":[{"given":"Marzieh","family":"Mansouri","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jean","family":"Villard","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mani","family":"Ramzi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ali","family":"Alavianmehr","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shirin","family":"Farjadian","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.humimm.2020.03.004_b0005","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1016\/j.bbmt.2016.12.638","article-title":"Donor killer immunoglobulin-like receptor haplotype B\/x induces severe acute graft-versus-host disease in the presence of human leukocyte antigen mismatch in T cell-replete hematopoietic cell transplantation","volume":"23","author":"Hosokai","year":"2017","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.humimm.2020.03.004_b0010","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1111\/j.1365-2141.2011.08823.x","article-title":"Use of NK cell activity in cure by transplant","volume":"155","author":"Leung","year":"2011","journal-title":"Br J Haematol"},{"key":"10.1016\/j.humimm.2020.03.004_b0015","doi-asserted-by":"crossref","first-page":"37","DOI":"10.4252\/wjsc.v9.i2.37","article-title":"Impact of T cells on hematopoietic stem and progenitor cell function: good guys or bad guys?","volume":"9","author":"Geerman","year":"2017","journal-title":"World J Stem Cells"},{"key":"10.1016\/j.humimm.2020.03.004_b0020","doi-asserted-by":"crossref","first-page":"626","DOI":"10.1016\/j.coi.2004.07.010","article-title":"Killer immunoglobulin-like receptors","volume":"16","author":"Moretta","year":"2004","journal-title":"Curr Opin Immunol"},{"key":"10.1016\/j.humimm.2020.03.004_b0025","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1186\/1479-5876-4-44","article-title":"Distribution of killer cell immunoglobulin-like receptors genes in the Italian Caucasian population","volume":"4","author":"Bontadini","year":"2006","journal-title":"J Transl Med"},{"key":"10.1016\/j.humimm.2020.03.004_b0030","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0180831","article-title":"KIR and their HLA Class I ligands: two more pieces towards completing the puzzle of chronic rejection and graft loss in kidney transplantation","volume":"12","author":"Littera","year":"2017","journal-title":"PLoS One"},{"key":"10.1016\/j.humimm.2020.03.004_b0035","doi-asserted-by":"crossref","first-page":"465","DOI":"10.3389\/fimmu.2017.00465","article-title":"Natural killer cells in graft-versus-host-disease after allogeneic hematopoietic cell transplantation","volume":"8","author":"Simonetta","year":"2017","journal-title":"Front Immunol"},{"key":"10.1016\/j.humimm.2020.03.004_b0040","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1111\/imm.12684","article-title":"Deciphering the killer-cell immunoglobulin-like receptor system at super-resolution for natural killer and T-cell biology","volume":"150","author":"Beziat","year":"2017","journal-title":"Immunology"},{"key":"10.1016\/j.humimm.2020.03.004_b0045","doi-asserted-by":"crossref","first-page":"2922","DOI":"10.4049\/jimmunol.180.5.2922","article-title":"KIR2DL4 differentially signals downstream functions in human NK cells through distinct structural modules","volume":"180","author":"Miah","year":"2008","journal-title":"J Immunol"},{"key":"10.1016\/j.humimm.2020.03.004_b0050","doi-asserted-by":"crossref","first-page":"42486","DOI":"10.1038\/srep42486","article-title":"Genetic polymorphism and evolutionary differentiation of Eastern Chinese Han: a comprehensive and comparative analysis on KIRs","volume":"7","author":"Yin","year":"2017","journal-title":"Sci Rep"},{"key":"10.1016\/j.humimm.2020.03.004_b0055","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1182\/blood-2008-01-132902","article-title":"The reactivity of Bw4+ HLA-B and HLA-A alleles with KIR3DL1: Implications for patient and donor suitability for haploidentical stem cell transplantations","volume":"112","author":"Foley","year":"2008","journal-title":"Blood"},{"key":"10.1016\/j.humimm.2020.03.004_b0060","doi-asserted-by":"crossref","first-page":"1179","DOI":"10.3389\/fimmu.2019.01179","article-title":"Killer Ig-like receptors (KIRs): their role in NK cell modulation and developments leading to their clinical exploitation","volume":"10","author":"Pende","year":"2019","journal-title":"Front Immunol"},{"key":"10.1016\/j.humimm.2020.03.004_b0065","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1016\/j.smim.2014.02.007","article-title":"NK cell self tolerance, responsiveness and missing self recognition","volume":"26","author":"Shifrin","year":"2014","journal-title":"Semin Immunol"},{"key":"10.1016\/j.humimm.2020.03.004_b0070","doi-asserted-by":"crossref","first-page":"1170","DOI":"10.1038\/s41409-018-0123-7","article-title":"Prognostic role of KIR genes and HLA-C after hematopoietic stem cell transplantation in a patient cohort with acute myeloid leukemia from a consanguineous community","volume":"53","author":"Gaafar","year":"2018","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.humimm.2020.03.004_b0075","doi-asserted-by":"crossref","first-page":"1618","DOI":"10.1038\/bmt.2010.24","article-title":"The role of killer immunoglobulin-like receptor haplotypes on the outcome of unrelated donor haematopoietic SCT for thalassaemia","volume":"45","author":"Littera","year":"2010","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.humimm.2020.03.004_b0080","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1016\/j.bbmt.2009.11.022","article-title":"Improved survival with inhibitory killer immunoglobulin receptor (KIR) gene mismatches and KIR haplotype B donors after nonmyeloablative, HLA-haploidentical bone marrow transplantation","volume":"16","author":"Symons","year":"2010","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.humimm.2020.03.004_b0085","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1111\/j.1751-553X.2010.01234.x","article-title":"An allelic typing method for 2DS4 variant used in study of haplotypes of killer cell immunoglobulin-like receptor gene","volume":"32","author":"Bao","year":"2010","journal-title":"Int J Lab Hematol"},{"key":"10.1016\/j.humimm.2020.03.004_b0090","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1111\/j.0001-2815.2004.00182.x","article-title":"The beneficial role of inhibitory KIR genes of HLA class I NK epitopes in haploidentically mismatched stem cell allografts may be masked by residual donor-alloreactive T cells causing GVHD","volume":"63","author":"Bishara","year":"2004","journal-title":"Tissue Antigens"},{"key":"10.1016\/j.humimm.2020.03.004_b0095","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1016\/j.humimm.2007.01.019","article-title":"Donor-recipient combinations of group A and B KIR haplotypes and HLA class I ligand affect the outcome of HLA-matched, sibling donor hematopoietic cell transplantation","volume":"68","author":"McQueen","year":"2007","journal-title":"Hum Immunol"},{"key":"10.1016\/j.humimm.2020.03.004_b0100","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1007\/978-1-62703-357-2_9","article-title":"Chimerism analysis following hematopoietic stem cell transplantation","volume":"999","author":"Murphy","year":"2013","journal-title":"Methods Mol Biol"},{"key":"10.1016\/j.humimm.2020.03.004_b0105","article-title":"WHO classification of tumours of haematopoietic and lymphoid tissues","author":"Swerdlow","year":"2017","journal-title":"Int Agency Res Cancer"},{"key":"10.1016\/j.humimm.2020.03.004_b0110","doi-asserted-by":"crossref","first-page":"966","DOI":"10.1111\/jcmm.12093","article-title":"Advances in the treatment of acute graft-versus-host disease","volume":"17","author":"Qian","year":"2013","journal-title":"J Cell Mol Med"},{"key":"10.1016\/j.humimm.2020.03.004_b0115","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1111\/j.1399-0039.2007.00923.x","article-title":"Facilitation of KIR genotyping by a PCR-SSP method that amplifies short DNA fragments","volume":"70","author":"Vilches","year":"2007","journal-title":"Tissue Antigens"},{"key":"10.1016\/j.humimm.2020.03.004_b0120","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1111\/j.1399-0039.2009.01259.x","article-title":"A novel duplex SSP-PCR typing method for KIR gene profiling","volume":"74","author":"Ashouri","year":"2009","journal-title":"Tissue Antigens"},{"key":"10.1016\/j.humimm.2020.03.004_b0125","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1038\/sj.leu.2402758","article-title":"Quantitative analysis of chimerism after allogeneic stem cell transplantation by PCR amplification of microsatellite markers and capillary electrophoresis with fluorescence detection: the Geneva experience","volume":"17","author":"Chalandon","year":"2003","journal-title":"Leukemia"},{"key":"10.1016\/j.humimm.2020.03.004_b0130","first-page":"1","article-title":"Assessing the impact of ABO incompatibility on major allogeneic hematopoietic stem cell transplant outcomes: a prospective, single-center, cohort study","volume":"41","author":"Soares","year":"2019","journal-title":"Hematol Transfus Cell Ther"},{"key":"10.1016\/j.humimm.2020.03.004_b0135","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1016\/j.bbmt.2017.09.014","article-title":"Young female donors do not increase the risk of graft-versus-host disease or impact overall outcomes in pediatric HLA-matched sibling hematopoietic stem cell transplantation","volume":"24","author":"Friedrich","year":"2018","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.humimm.2020.03.004_b0140","doi-asserted-by":"crossref","first-page":"1400","DOI":"10.1016\/j.bbmt.2009.07.002","article-title":"Minor ABO-mismatches are risk factors for acute graft-versus-host disease in hematopoietic stem cell transplant patients","volume":"15","author":"Ludajic","year":"2009","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.humimm.2020.03.004_b0145","doi-asserted-by":"crossref","first-page":"1477","DOI":"10.3324\/haematol.2015.125294","article-title":"Risks and benefits of sex-mismatched hematopoietic cell transplantation differ according to conditioning strategy","volume":"100","author":"Nakasone","year":"2015","journal-title":"Haematologica"},{"key":"10.1016\/j.humimm.2020.03.004_b0150","article-title":"Analysis of immunogenetic factors in myelodysplastic syndromes (MDS) reveals potential pathogenic role cytokine genotypes such as TGF-\u03b2","author":"Serio","year":"2007","journal-title":"Am Soc Hematol"},{"key":"10.1016\/j.humimm.2020.03.004_b0155","doi-asserted-by":"crossref","first-page":"768","DOI":"10.1111\/jvh.12698","article-title":"KIR2DL3 and the KIR ligand groups HLA-A-Bw4 and HLA-C2 predict the outcome of hepatitis B virus infection","volume":"24","author":"Di Bona","year":"2017","journal-title":"J Viral Hepat"},{"key":"10.1016\/j.humimm.2020.03.004_b0160","doi-asserted-by":"crossref","first-page":"872","DOI":"10.1126\/science.1097670","article-title":"HLA and NK cell inhibitory receptor genes in resolving hepatitis C virus infection","volume":"305","author":"Khakoo","year":"2004","journal-title":"Science"},{"key":"10.1016\/j.humimm.2020.03.004_b0165","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1016\/j.humimm.2018.01.012","article-title":"KIR2DS1, 2DS5, 3DS1 and KIR2DL5 are associated with the risk of head and neck squamous cell carcinoma in Iranians","volume":"79","author":"Barani","year":"2018","journal-title":"Hum Immunol"},{"key":"10.1016\/j.humimm.2020.03.004_b0170","doi-asserted-by":"crossref","first-page":"760","DOI":"10.3389\/fimmu.2017.00760","article-title":"NK cell exhaustion","volume":"8","author":"Bi","year":"2017","journal-title":"Front Immunol"},{"key":"10.1016\/j.humimm.2020.03.004_b0175","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1111\/imm.12606","article-title":"A vision of KIR variation at super resolution","volume":"148","author":"Hammond","year":"2016","journal-title":"Immunology"},{"key":"10.1016\/j.humimm.2020.03.004_b0180","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/j.leukres.2009.04.022","article-title":"Killer cell immunoglobulin-like receptor gene polymorphisms in patients with leukemia: possible association with susceptibility to the disease","volume":"34","author":"Zhang","year":"2010","journal-title":"Leuk Res"},{"key":"10.1016\/j.humimm.2020.03.004_b0185","doi-asserted-by":"crossref","first-page":"2902","DOI":"10.3109\/10428194.2015.1014361","article-title":"Natural killer cell killer immunoglobulin-like gene receptor polymorphisms in non-Hodgkin lymphoma: possible association with clinical course","volume":"56","author":"Pamuk","year":"2015","journal-title":"Leuk Lymphoma"},{"key":"10.1016\/j.humimm.2020.03.004_b0190","doi-asserted-by":"crossref","first-page":"2770","DOI":"10.1182\/blood-2012-07-440495","article-title":"Lack of association between KIR genes and acute lymphoblastic leukemia in children","volume":"120","author":"Babor","year":"2012","journal-title":"Blood"},{"key":"10.1016\/j.humimm.2020.03.004_b0195","doi-asserted-by":"crossref","first-page":"41","DOI":"10.3389\/fimmu.2017.00041","article-title":"Reduction of relapse after unrelated donor stem cell transplantation by KIR-based graft selection","volume":"8","author":"Heidenreich","year":"2017","journal-title":"Front Immunol"},{"key":"10.1016\/j.humimm.2020.03.004_b0200","doi-asserted-by":"crossref","first-page":"2002","DOI":"10.1038\/sj.leu.2403525","article-title":"Identification of natural killer cell receptor phenotypes associated with leukemia","volume":"18","author":"Verheyden","year":"2004","journal-title":"Leukemia"},{"key":"10.1016\/j.humimm.2020.03.004_b0205","doi-asserted-by":"crossref","first-page":"2497","DOI":"10.1182\/blood-2013-11-540625","article-title":"The role of KIR genes and their cognate HLA class I ligands in childhood acute lymphoblastic leukemia","volume":"123","author":"de Smith","year":"2014","journal-title":"Blood"},{"key":"10.1016\/j.humimm.2020.03.004_b0210","doi-asserted-by":"crossref","first-page":"2552","DOI":"10.1038\/leu.2017.151","article-title":"Impact of killer-immunoglobulin-like receptor and human leukocyte antigen genotypes on the efficacy of immunotherapy in acute myeloid leukemia","volume":"31","author":"Bernson","year":"2017","journal-title":"Leukemia"},{"key":"10.1016\/j.humimm.2020.03.004_b0215","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1016\/j.bbmt.2015.10.004","article-title":"KIR2DS4 and its variant KIR1D are associated with acute graft-versus-host disease, cytomegalovirus, and overall survival after sibling-related HLA-matched transplantation in patients with donors with KIR gene haplotype A","volume":"22","author":"Wu","year":"2016","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.humimm.2020.03.004_b0220","doi-asserted-by":"crossref","first-page":"1024","DOI":"10.1097\/01.tp.0000235859.24513.43","article-title":"Low number of donor activating killer immunoglobulin-like receptors (KIR) genes but not KIR-ligand mismatch prevents relapse and improves disease-free survival in leukemia patients after in vivo T-cell depleted unrelated stem cell transplantation","volume":"82","author":"Kroger","year":"2006","journal-title":"Transplantation"},{"key":"10.1016\/j.humimm.2020.03.004_b0225","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1038\/sj.bmt.1705089","article-title":"Killer Ig-like receptor (KIR) compatibility plays a role in the prevalence of acute GVHD in unrelated hematopoietic cell transplants for AML","volume":"36","author":"Sun","year":"2005","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.humimm.2020.03.004_b0230","doi-asserted-by":"crossref","first-page":"405","DOI":"10.3389\/fimmu.2014.00405","article-title":"Donor haplotype B of NK KIR receptor reduces the relapse risk in HLA-identical sibling hematopoietic stem cell transplantation of AML patients","volume":"5","author":"Impola","year":"2014","journal-title":"Front Immunol"},{"key":"10.1016\/j.humimm.2020.03.004_b0235","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1182\/blood-2008-07-171926","article-title":"Donors with group B KIR haplotypes improve relapse-free survival after unrelated hematopoietic cell transplantation for acute myelogenous leukemia","volume":"113","author":"Cooley","year":"2009","journal-title":"Blood"},{"key":"10.1016\/j.humimm.2020.03.004_b0240","doi-asserted-by":"crossref","first-page":"4592","DOI":"10.4049\/jimmunol.1302517","article-title":"Donor killer cell Ig-like receptor B haplotypes, recipient HLA-C1, and HLA-C mismatch enhance the clinical benefit of unrelated transplantation for acute myelogenous leukemia","volume":"192","author":"Cooley","year":"2014","journal-title":"J Immunol"},{"key":"10.1016\/j.humimm.2020.03.004_b0245","doi-asserted-by":"crossref","first-page":"1521","DOI":"10.1182\/blood-2003-02-0438","article-title":"The impact of donor KIR and patient HLA-C genotypes on outcome following HLA-identical sibling hematopoietic stem cell transplantation for myeloid leukemia","volume":"103","author":"Cook","year":"2004","journal-title":"Blood"},{"key":"10.1016\/j.humimm.2020.03.004_b0250","doi-asserted-by":"crossref","first-page":"4878","DOI":"10.1182\/blood-2004-12-4825","article-title":"Improved outcome in HLA-identical sibling hematopoietic stem-cell transplantation for acute myelogenous leukemia predicted by KIR and HLA genotypes","volume":"105","author":"Hsu","year":"2005","journal-title":"Blood"},{"key":"10.1016\/j.humimm.2020.03.004_b0255","doi-asserted-by":"crossref","first-page":"20","DOI":"10.3324\/haematol.2015.139105","article-title":"Risk factors for relapse after allogeneic transplantation in acute myeloid leukemia","volume":"101","author":"Ossenkoppele","year":"2016","journal-title":"Haematologica"},{"key":"10.1016\/j.humimm.2020.03.004_b0260","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1016\/j.bbmt.2017.10.019","article-title":"Impact of allogeneic stem cell transplantation in first complete remission in acute myeloid leukemia: a national population-based cohort study","volume":"24","author":"Ostgard","year":"2018","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.humimm.2020.03.004_b0265","doi-asserted-by":"crossref","first-page":"675","DOI":"10.3389\/fimmu.2017.00675","article-title":"HLA-Bw4-I-80 isoform differentially influences clinical outcome as compared to HLA-Bw4-T-80 and HLA-A-Bw4 isoforms in rituximab or dinutuximab-based cancer immunotherapy","volume":"8","author":"Erbe","year":"2017","journal-title":"Front Immunol"}],"container-title":["Human Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0198885920300392?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0198885920300392?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,4,30]],"date-time":"2026-04-30T05:53:33Z","timestamp":1777528413000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0198885920300392"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,6]]},"references-count":53,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2020,6]]}},"alternative-id":["S0198885920300392"],"URL":"https:\/\/doi.org\/10.1016\/j.humimm.2020.03.004","relation":{},"ISSN":["0198-8859"],"issn-type":[{"value":"0198-8859","type":"print"}],"subject":[],"published":{"date-parts":[[2020,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Impact of donor KIRs and recipient KIR\/HLA class I combinations on GVHD in patients with acute leukemia after HLA-matched sibling HSCT","name":"articletitle","label":"Article Title"},{"value":"Human Immunology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.humimm.2020.03.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 American Society for Histocompatibility and Immunogenetics. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}